207 related articles for article (PubMed ID: 32378117)
1. Multimodality imaging approach to Fabry cardiomyopathy: Any role for nuclear cardiology?
Acampa W; D'Antonio A; Imbriaco M; Pisani A; Cuocolo A
J Nucl Cardiol; 2022 Jun; 29(3):1439-1445. PubMed ID: 32378117
[TBL] [Abstract][Full Text] [Related]
2. Role of cardiac imaging in Anderson-Fabry cardiomyopathy.
Serra W; Marziliano N
Cardiovasc Ultrasound; 2019 Jan; 17(1):1. PubMed ID: 30674321
[TBL] [Abstract][Full Text] [Related]
3. Anderson-Fabry cardiomyopathy: prevalence, pathophysiology, diagnosis and treatment.
Putko BN; Wen K; Thompson RB; Mullen J; Shanks M; Yogasundaram H; Sergi C; Oudit GY
Heart Fail Rev; 2015 Mar; 20(2):179-91. PubMed ID: 25030479
[TBL] [Abstract][Full Text] [Related]
4. Multimodality imaging for the diagnosis of infiltrative cardiomyopathies.
Vidula MK; Bravo PE
Heart; 2022 Jan; 108(2):98-104. PubMed ID: 34039679
[TBL] [Abstract][Full Text] [Related]
5. Sex Differences in Anderson-Fabry Cardiomyopathy: Clinical, Genetic, and Imaging Analysis in Women.
Faro DC; Losi V; Rodolico MS; Torrisi EM; Colomba P; Duro G; Monte IP
Genes (Basel); 2023 Sep; 14(9):. PubMed ID: 37761944
[TBL] [Abstract][Full Text] [Related]
6. Multimodality imaging in Fabry cardiomyopathy: from early diagnosis to therapeutic targets.
Militaru S; Ginghina C; Popescu BA; Saftoiu A; Linhart A; Jurcut R
Eur Heart J Cardiovasc Imaging; 2018 Dec; 19(12):1313-1322. PubMed ID: 30247528
[TBL] [Abstract][Full Text] [Related]
7. Hybrid positron emission tomography-magnetic resonance imaging for assessing different stages of cardiac impairment in patients with Anderson-Fabry disease: AFFINITY study group.
Imbriaco M; Nappi C; Ponsiglione A; Pisani A; Dell'Aversana S; Nicolai E; Spinelli L; Aiello M; Diomiaiuti CT; Riccio E; Esposito R; Galderisi M; Losi M; Greiser A; Chow K; Cuocolo A
Eur Heart J Cardiovasc Imaging; 2019 Sep; 20(9):1004-1011. PubMed ID: 30879055
[TBL] [Abstract][Full Text] [Related]
8. Severe hypertrophic cardiomyopathy in a patient with atypical Anderson-Fabry disease.
Masarone D; Duro G; Dellegrottaglie S; Colomba P; Rubino M; Cirillo A; Pisani A; Caiazza M; Elliott PM; Calabrò P; Pacileo G; Limongelli G
Future Cardiol; 2017 Nov; 13(6):521-527. PubMed ID: 28936893
[TBL] [Abstract][Full Text] [Related]
9. Multimodality Imaging Assessment of Fabry Disease.
Tower-Rader A; Jaber WA
Circ Cardiovasc Imaging; 2019 Nov; 12(11):e009013. PubMed ID: 31718277
[TBL] [Abstract][Full Text] [Related]
10. The Role of Cardiac Imaging in the Diagnosis and Management of Anderson-Fabry Disease.
Perry R; Shah R; Saiedi M; Patil S; Ganesan A; Linhart A; Selvanayagam JB
JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1230-1242. PubMed ID: 31272606
[TBL] [Abstract][Full Text] [Related]
11. First experience of simultaneous PET/MRI for the early detection of cardiac involvement in patients with Anderson-Fabry disease.
Nappi C; Altiero M; Imbriaco M; Nicolai E; Giudice CA; Aiello M; Diomiaiuti CT; Pisani A; Spinelli L; Cuocolo A
Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1025-31. PubMed ID: 25808629
[TBL] [Abstract][Full Text] [Related]
12. Segment-by-segment assessment of left ventricular myocardial affection in Anderson-Fabry disease by non-enhanced T1-mapping.
Walter TC; Knobloch G; Canaan-Kuehl S; Greiser A; Sandek A; Blaschke D; Denecke T; Hamm B; Makowski MR
Acta Radiol; 2017 Aug; 58(8):914-921. PubMed ID: 27799574
[TBL] [Abstract][Full Text] [Related]
13. Left atrial strain correlates with severity of cardiac involvement in Anderson-Fabry disease.
Halfmann MC; Altmann S; Schoepf UJ; Reichardt C; Hennermann JB; Kreitner KF; Kloeckner R; Hahn F; Dueber C; Varga-Szemes A; Kampmann C; Emrich T
Eur Radiol; 2023 Mar; 33(3):2039-2051. PubMed ID: 36322192
[TBL] [Abstract][Full Text] [Related]
14. Prominent longitudinal strain reduction of left ventricular basal segments in treatment-naïve Anderson-Fabry disease patients.
Esposito R; Galderisi M; Santoro C; Imbriaco M; Riccio E; Maria Pellegrino A; Sorrentino R; Lembo M; Citro R; Angela Losi M; Spinelli L; Trimarco B; Pisani A
Eur Heart J Cardiovasc Imaging; 2019 Apr; 20(4):438-445. PubMed ID: 30085001
[TBL] [Abstract][Full Text] [Related]
15. Multimodality imaging for pre-clinical assessment of Fabry's cardiomyopathy.
Madonna R; Cevik C; Cocco N
Eur Heart J Cardiovasc Imaging; 2014 Oct; 15(10):1094-100. PubMed ID: 24904036
[TBL] [Abstract][Full Text] [Related]
16. Layer-specific longitudinal strain in Anderson-Fabry disease at diagnosis: A speckle tracking echocardiography analysis.
Esposito R; Santoro C; Sorrentino R; Riccio E; Citro R; Buonauro A; Di Risi T; Imbriaco M; Trimarco B; Pisani A; Galderisi M;
Echocardiography; 2019 Jul; 36(7):1273-1281. PubMed ID: 31246327
[TBL] [Abstract][Full Text] [Related]
17. Clinical study of left ventricular structure and function in patients with Anderson-Fabry disease before and after enzyme replacement therapy.
Huang S; Wang J; Zhang W; Gao F; Chen Y; Shui W; Xing X; Chen S; Mu Y
J Clin Ultrasound; 2024 Jan; 52(1):20-29. PubMed ID: 37883130
[TBL] [Abstract][Full Text] [Related]
18. Severe Late-Onset Fabry Cardiomyopathy Unmasked by a Multimodality Imaging Approach.
Visoiu IS; Ciobanu AO; Nicula AI; Iascone M; Jurcut R; Vinereanu D; Rimbas RC
Circ Cardiovasc Imaging; 2019 Nov; 12(11):e009709. PubMed ID: 31630529
[No Abstract] [Full Text] [Related]
19. Biomarkers and Imaging Findings of Anderson-Fabry Disease-What We Know Now.
Beirão I; Cabrita A; Torres M; Silva F; Aguiar P; Laranjeira F; Gomes AM
Diseases; 2017 Jun; 5(2):. PubMed ID: 28933368
[TBL] [Abstract][Full Text] [Related]
20. Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.
Williams LK; Forero JF; Popovic ZB; Phelan D; Delgado D; Rakowski H; Wintersperger BJ; Thavendiranathan P
J Cardiovasc Magn Reson; 2017 Aug; 19(1):61. PubMed ID: 28784140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
